In order to identify genes capable of inhibiting apoptosis induced by dierent pathways, without inducing proliferation we have performed retroviral insertion mutagenesis in the IL-3 dependent bone marrow derived Baf-3 cell line. Out of 200 mutants obtained in three separate mutagenesis experiments, four mutants were resistant to multiple apoptosis inducing pathways (including growth factor starvation, staurosporine, etoposide and cyclosporin A) and did not proliferate in the absence of IL-3. These four mutants overexpress the bcl-X gene following a retroviral insertion 5' of the translation initiation site. These results indicate that the bcl-X gene is a major pleiotropic anti-apoptotic gene in Baf-3 cells. They also suggest that the Bcl-2 family of genes might be the only one capable of inhibiting apoptosis induced by multiple pathways without inducing cell proliferation.
Introduction
Apoptosis, an autonomous cell suicide pathway characterized by speci®c morphological changes, plays a central role in the development and homeostasis of multi-cellular organisms. Although our knowledge of the mechanisms involved in the regulation of this process has grown considerably in the last few years, our understanding of the function as well as the nature of the genes involved in this process remains incomplete (Jacobson et al., 1997; Nagata, 1997) . Genetic studies in C. elegans have led to the identi®cation of three genes ced-3, ced-4 and ced-9 involved in the central regulation of the apoptotic process (Ellis and Horvitz, 1986; Ellis et al., 1991; Hengartner et al., 1992) . A large number of mammalian homologues have now been identi®ed for ced-3 and ced-9 (Alnemri et al., 1996; Henkart, 1996; Yang and Korsmeyer, 1996) . Ced-3 is necessary for the induction of the apoptotic process and was found to be homologous to the mammalian gene ICE, a cysteine protease with aspartate speci®city (Miura et al., 1993; Yuan et al., 1993) . At present more than 10 proteins with similar characteristics have been described. They have recently been renamed caspases (Alnemri et al., 1996) . Ced-9 is essential for the inhibition of apoptosis and is homologous to the bcl-2 gene which was ®rst identi®ed in human follicular B-cell lymphomas where it is overexpressed following the t(14;18) translocation (Hengartner and Horvitz, 1994) . At least 15 genes homologous to bcl-2 have been described. Functionally they are subdivided into two groups: genes like bcl-2, bcl-X or nr13 which delay death and genes like bax, bak or bad which promote death. These two groups of proteins can form homo or heterodimers with, in the latter case, one monomer antagonising or enhancing the function of the other (Oltvai and Korsmeyer, 1994; Yang and Korsmeyer, 1996) . Overexpression of the anti-apoptotic gene bcl-2 delays the onset of apoptosis induced by a diversity of apoptotic stimuli including growth factor withdrawal, genotoxic damage, c-myc overexpression and apoptosis induction through the death receptor Fas (Sentman et al., 1991; Yang and Korsmeyer, 1996) . The inhibition of apoptosis by Bcl-2 has been correlated with the inhibition of various biochemical events which occur in apoptotic cells. These include Ca ++ redistribution inside the cell (Bay et al., 1993; Lam et al., 1994) , free radicals metabolisms (Hockenbery et al., 1993) and mitochondrial permeability transition (Zamzami et al., 1996) . More recently it was shown that another anti-apoptotic member of the Bcl-2 family, the protein Bcl-XL, was structurally homologous to the pore forming unit of diphtheria toxin and that it had the capacity to form an ion channel in synthetic membranes (Muchmore et al., 1996; Minn et al., 1997) . This would suggest that these proteins are regulating the ion permeability of the intracellular membranes to which they are associated. Nevertheless it is still unknown how this property aects the regulation of apoptosis. Inhibition of apoptosis by the Bcl-2 family of genes is correlated with arrest in the G1 phase of the cell cycle (Yang and Korsmeyer, 1996) . This appears to result from an active process, although the mechanisms involved are unknown (Marvel et al., 1994; Borner, 1996; Linette et al., 1996; Vairo et al., 1996) . Other genes capable of inhibiting apoptosis have been described (White, 1996) . These include proteins of viral origin like CrmA or p35 which act via the inhibition of dierent members of the caspase family (Bump et al., 1995; Martinou et al., 1995) , the IAP proteins which act through an unknown mechanism (Liston et al., 1996) and some cellular oncogenes such as Raf, BCR-ABL or E2A-HLF (Cleveland et al., 1994; Sanchez-Garcia and Grutz, 1995; Inaba et al., 1996; Gotoh and Broxmeyer, 1997) . The latter group contains proteins which act on multiple pathways and can induce both cell proliferation and survival.
In order to identify genes capable of inhibiting apoptosis induced by multiple pathways without inducing cell proliferation, we have performed retroviral insertion mutagenesis of Baf-3 cells. Replication de®cient MPSV derived retroviral vectors containing the bacterial selection gene neo or the bgal reporter gene were used to infect Baf-3 cells (Stocking et al., 1993; Cosset et al., 1995) . Integration of a replication de®cient provirus DNA can occur within or close to cellular genes and induce untimely or disregulated expression. In some cases the retroviral insertion can lead to the production of an altered protein (Con, 1991; Jonkers and Berns, 1996) . This mutagenesis approach has one major advantage over random mutations induced by drugs or irradiation, which is that the modi®ed gene can be traced using the provirus DNA as a marker.
In this study, we describe the results of three independent retroviral insertion mutagenesis experiments. 204 independent clones which survived the ®rst IL-3 starvation round were tested for their resistance to IL-3 starvation or drug induced apoptosis. Nineteen clones were highly resistant to IL-3 starvation and among those, four were resistant to multiple apoptosis inducing pathways and did not proliferate in the absence of IL-3. These four clones all show a disregulated expression of the bcl-X gene resulting from a retroviral insertion in the 5' region of the gene.
Results

Selection of pleiotropic apoptosis resistant mutants following retroviral insertion mutagenesis
Baf-3 cells were infected with replication de®cient retrovirus as described in the Methods. Cells which had potentially activated an apoptosis inhibitory gene were selected for their capacity to survive in the absence of IL-3. The selection protocol we used was optimised in order to eliminate almost all parental Baf-3 cells keeping most cells overexpressing an apoptosis inhibitory gene alive. Baf-3 cells overexpressing the human bcl-2 gene were used as a positive control (Marvel et al., 1994; Leverrier et al., 1996) . The frequency of survivors for the bcl-2 overexpressing cells following the selection protocol was at least 10 5 times higher than the one obtained with parental Baf-3 cells.
Three independent mutagenesis experiments described in Materials and methods were performed. A total of 204 clones which survived the selection procedure were analysed for their resistance to IL-3 starvation (Table 1) . Among the 204 clones, 19 showed a strong, reproducible resistance to apoptosis induction i.e. the percentage of viable cells after 24 h culture in the absence of IL-3 was at least eightfold higher than the one obtained with parental cells. To identify mutants resistant to multiple apoptosis inducing pathways, these 19 clones were further analysed for their resistance to staurosporine a widely used apoptosis inducing drug (Jacobson et al., 1996) . Among the 19 clones four showed a reproducible resistance to staurosporine. These four clones were also resistant to apoptosis induced by etoposide or cyclosporin A (Figure 1a) . Their proliferation in the absence of IL-3 was measured after 28 h culture by BrdU incorporation. Results in Figure 1b show that for all clones, cells accumulated in the G1 phase of the cell cycle in the absence of IL-3. Hence these clones potentially expressed a pleiotropic anti-apoptotic gene which did not induce cell proliferation.
All clones resistant to multiple apoptosis inducing pathways express increased Bcl-X RNA and protein levels
Since the four mutant clones displayed a phenotype similar to the one obtained following overexpression of bcl-2, the level of RNA coding for dierent members of the Bcl-2 family was measured by Northern analysis (Figure 2 , clones 1 to 4). Seven clones which resisted mainly to IL-3 starvation were also analysed (Figure 2 , clones 5 to 11). As shown in Figure 2 clones 5 to 11 expressed levels of mRNA coding for Bcl-X, Bcl-2, or Bax which are similar to those detected in parental Baf-3 cells. For Bcl-2, variable levels of the 7.5 Kb mRNA were detected in dierent clones. However, none of them expressed a level superior to the parental Baf-3 cells. In some clones no Bcl-2 mRNA could be detected as previously reported for some Baf-3 sub-lines (Kinoshita et al., 1995) . In contrast, increased levels of mRNA coding for Bcl-X were found in the four mutants which are resistant to multiple apoptosis inducing pathways. RNA levels coding for Bcl-2 or Bax were similar to those detected in parental Baf-3 cells. This increased Bcl-X mRNA level resulted in Bcl-XL protein overexpression as evidenced by Western blot analysis ( Figure 3 ). As these mutant clones overexpress Bcl-X they will from now on be designated Baf-Bcl-X-1, Baf-Bcl-X-2, Baf-Bcl-X-3 and Baf-Bcl-X-4.
We have previously shown that in Baf-3 cells Bcl-X expression is regulated by IL-3 and that in the absence of IL-3 Bcl-X down-regulation correlates with the onset of apoptosis (Leverrier et al., 1997) . To determine if bcl-X gene expression in the mutants was still regulated by IL-3, we have measured Bcl-X protein levels in these cells at dierent times following IL-3 starvation. Figure  3 shows that although the level of the Bcl-XL protein in the Baf-Bcl-X mutants decreased slightly in the absence of IL-3, it remained high for up to 15 h after IL-3 removal. Similar results were obtained at the RNA level (data not shown). These results indicate that the expression of at least one of the bcl-X alleles is disregulated or enhanced in these mutants. Bcl-X mRNA overexpression is due to a retroviral integration in the bcl-X gene locus
In order to establish if the disregulated expression of the bcl-X gene resulted from the integration of a provirus in the proximity of the bcl-X gene, we have analysed the bcl-X locus in the dierent mutants by Southern blot. When genomic DNA digested with EcoRI was hybridized with a Bcl-X probe, gene rearrangement was observed in all four Baf-Bcl-X clones ( Figure 4b ) but not in parental Baf-3 cells. To determine the number of provirus integrated in the genome as well as their possible co-localization with the rearranged bcl-X allele, the Southern blot was also hybridized with the probe coding for the neo or the bgal gene. A schematic map of the two retroviruses we have used is shown in Figure 4a . Only one band hybridizing with Neo ( Figure 4b ) was detected in all mutants infected by the M3Pneo-sup retrovirus. For the Baf-Bcl-X-4 mutant the number of proviral insertion was determined by Southern blot using DNA digested with a restriction enzyme (HindIII) which cuts only once in the pMFG nlsLacZ retrovirus. Only one band hybridizing with the bgal probe was detected in that mutant (data not shown). As a whole these results indicate that only one integral provirus is integrated in each of the Baf-Bcl-X mutants. As Bcl-X is overexpressed in all clones resistant to multiple apoptosis inducing pathways. Northern blot analysis was performed on 10 mg RNA from clones resistant to multiple apoptosis inducing pathways (1 to 4) or clones resistant to IL-3 starvation only (5 to 11). Expression of bcl-X, bcl-2, bax and GAPDH was detected using the probes described in Materials and methods 0 4 7.5 0 7.5 15 0 7.5 15 0 7.5 15 0 7.5 15
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Baf- There are no EcoRI restriction site in the M3Pneo-sup provirus. Baf-Bcl-X-1, Baf-Bcl-X-2, and Baf-Bcl-X-3 were obtained following infection with M3Pneo-sup containing retrovirus and Baf-Bcl-X-4 following infection with pMFG nlsLacZ containing retrovirus. (b) Southern blot analysis was performed on 10 mg EcoRI digested DNA from Baf-3 cells, Baf-Bcl-X-1 (1), Baf-Bcl-X-2 (2), Baf-Bcl-X-3 (3) and Baf-Bcl-X-4 (4). The Bcl-X, neo, LacZ and U3MPSV probes were used as described in Materials and methods. U3 hybridizing bands which colocalize with the bcl-X rearranged bands are indicated by arrows integration of solo LTR can also lead to the disregulation of gene expression we have used a probe speci®c for the U3 sequence of the MPSV LTR to identify that type of integration (Cuypers et al., 1984; Robinson and Gagnon, 1986) . Figure 4b shows that as expected the U3 probe hybridizes with the same band as the Neo probe for Baf-Bcl-X-1, Baf-Bcl-X-2 and Baf-Bcl-X-3 mutants. Moreover in all three mutants one to three additional bands are found which are likely to correspond to solo LTR integration. For the Baf-Bcl-X-1 and Baf-Bcl-X-2 mutants one of the bands hybridizing only with the U3 probe colocalizes with the rearranged bcl-X allele indicating that in these mutant a solo LTR insertion might be responsible for the rearrangement. In the case of the Baf-Bcl-X-3 mutant the band hybridizing with the neo gene and the U3 probe co-localized with the rearranged bcl-X allele suggesting that a whole provirus is responsible for the rearrangement of the bcl-X gene. The two bands hybridizing with the U3 probe in the Baf-Bcl-X-4 mutant correspond to the DNA fragments containing the 5' and 3' LTR of the provirus which are generated following digestion with EcoRI, indicating that only one provirus was inserted in the genome of that mutant. This has been con®rmed using other restriction enzymes (data not shown). These results suggest that in all four mutants a whole provirus or a solo LTR has integrated in one of the bcl-X allele and is inducing the disregulated expression of the bcl-X gene.
Loss of the rearranged bcl-X allele is associated with a strong decrease in the resistance to apoptosis induced by multiple pathways
To demonstrate that the viral integration in the bcl-X locus is responsible for bcl-X overexpression and the resistance to apoptosis, we have searched for subclones of the dierent mutants which had spontaneously lost the capacity to survive apoptosis induced by multiple pathways. All Baf-Bcl-X mutants were cloned by limiting dilution and 12 sub-clones of each mutant were analysed for their resistance to apoptosis. Only one clone derived from the Baf-Bcl-X-2 mutant had lost resistance to apoptosis induced by IL-3 starvation (Figure 5a ), treatment with staurosporine, etoposide or cyclosporin A (data not shown). Southern blot analysis showed that the rearranged bcl-X allele as well as the band hybridizing with the U3 probe which colocalized with the rearranged bcl-X allele were lost in that subclone (Figure 5c ). The other U3 hybridizing band found in the parental clone was still detectable con®rming this was eectively a Baf-Bcl-X-2 subclone. Finally Northern and Western blot analysis con®rmed that the provirus integration was responsible for the bcl-X allele rearrangement and the Bcl-X mRNA overexpression, as the mRNA (Figure 5b ) and the protein levels (data not shown) were strongly decreased in the sub-clone having lost the bcl-X locus rearrangement.
Mapping of the retroviral integration site
Localization of the provirus was done by PCR analysis (Figure 6a ). Primers were chosen at the 5' and 3' end of the two mouse bcl-X coding exons and a long template PCR reaction was performed using one of these primers and the U3 speci®c primer as described in the Methods. A schematic localization of the primers is 
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Baf-3 1 2 kb Figure 5 Characterization of an apoptosis-sensitive Baf-Bcl-X-2 subclone. (a) Survival in the absence of IL-3. Baf-3, Baf-Bcl-X-2 and the Baf-Bcl-X-2 sub-clone cells were cultured in absence of IL-3 for 16 h. Viability was measured by propidium iodide exclusion. Results from two independent experiments are expressed as percent of viable cells. Standard deviations are indicated (vertical bars). (b and c) Molecular characterisation of the apoptosis-sensitive sub-clone. Bcl-X mRNA levels (b) were measured by Northern analysis as described in Materials and methods. Southern blot analysis (c) was performed on 10 mg of EcoRI digested DNA puri®ed from Baf-3, Baf-Bcl-X-2 (1) or the Baf-Bcl-X-2 apoptosis-sensitive sub-clone (2). Southern blots were hybridized with the Bcl-X or U3 probes described in Materials and methods Bcl-X major anti-apoptotic gene in Baf-3 cells J Thomas et al a b Figure 6 Mapping of the retroviral integration site in the bcl-X locus. (a) Provirus insertion sites in the four Baf-Bcl-X mutants were determined by PCR as described in the text and are indicated by arrows. The insertion point for Baf-Bcl-X-1 is at 7209, BafBcl-X-2 is at 7200, Baf-Bcl-X-3 is at 7928 and Baf-Bcl-X-4 is at 7393. Primers used for mapping of the insertion site are indicated by arrows A to D (sequences are given in the methods). (b) Comparison of the human and mouse bcl-X 5' untranslated region DNA sequence. Nucleotide 732 to 815 are absent from the two published cDNA sequence and are likely to be part of an intron which is also found in the human 5' untranslated region. The limits of the intron in the human sequence is shown by arrows Bcl-X major anti-apoptotic gene in Baf-3 cells J Thomas et al shown in Figure 6a . A PCR product was obtained for all clones when the bcl-X 5' primer C and the U3 primer B were used indicating that for all four mutants the provirus integration had occurred in the 5' untranslated region of the bcl-X gene. The dierent PCR fragments were sequenced as described in the Methods. The retroviral insertion site for the four mutants is given in Figure 6a . For mutants Baf-Bcl-X-1 and Baf-Bcl-X-2 insertion of a solo LTR was con®rmed by sequencing (data not shown). The longer bcl-X 5' untranslated sequence obtained in the Baf-Bcl-X-3 mutant is given in Figure 6b . Comparison with the sequenced human promoter region (Figure 6b) shows that human and mouse 5' untranslated region are highly homologous: 77.5% for the total 927 nucleotides we have sequenced 5' of the ATG. The human 5' untranslated region contains one non coding exon and an intron. The intron seems to be conserved between human and mouse as its sequence is not found in either of the two published cDNA sequences (Fang et al., 1994; Gonzalez-Garcia et al., 1994) . However, comparison of the DNA sequence of the mbcl-X 5' untranslated region with the two published mbcl-X cDNA sequence (data not shown) does not allow to determine the exact intron exon structure of the mbcl-X 5' untranslated region as there is some discrepancy in the published cDNA sequence in that region.
Discussion
In order to identify genes capable of inhibiting apoptosis induced by multiple pathways without inducing proliferation in the absence of growth factors, we have used retroviral insertion mutagenesis.
Four clones with such a phenotype were obtained out of a total of 40 million infected cells. All of them overexpressed the bcl-X gene following a retroviral insertion in the 5' untranslated region of the gene. Two types of oncogenes have been revealed by retroviral insertion: oncogenes like myc (Robinson and Gagnon, 1986) or ras (Sorensen et al., 1996) whose overexpression can lead to tumour formation or oncogenes like the EGF receptor or erb-B (Nilsen et al., 1985) where the gene sequence is disrupted and the protein sequence is altered. In the Baf-Bcl-X mutants all insertions have occurred in the 5' untranslated region of the bcl-X gene. Hence, it is likely that the resistance to apoptosis was due to the overexpression of the gene and protein and not to an alteration of the Bcl-X protein sequence. This is supported by results obtained with the Baf-Bcl-X-2 sub-clone where loss of the bcl-X gene overexpression was associated with an increased susceptibility to apoptosis. This is also in agreement with previously published results showing that bcl-X overexpression by itself protects cells against apoptosis (Boise et al., 1993) . Retroviral insertion can induce the overexpression of a gene by at least two mechanisms: promoter insertion where the viral LTR is used as a promoter for gene expression or enhancer insertion where the LTR acts as an enhancer on the gene promoter (Jonkers and Berns, 1996) . In our mutants both mechanisms could be involved as all the proviral insertions are in the same transcriptional orientation as the bcl-X gene. All insertions points are 5' of the ®rst coding exon. This type of insertion has been found in the majority of tumours where c-myc is overexpressed following Avian Leukosis Virus insertion or in some T cell tumours overexpressing H-Ras following MuLV insertion (Robinson and Gagnon, 1986; Sorensen et al., 1996) .
The fact that all four clones resistant to multiple apoptosis pathways which did not proliferate in the absence of IL-3 overexpress the bcl-X gene indicates that this is the major gene leading to such a phenotype in Baf-3 cells. Indeed, if as a consequence of retroviral insertion, overexpression of two dierent genes lead to the same phenotype, the likelihood of obtaining at least one out of four mutants overexpressing the other gene would be over 90%. An alternative interpretation would be that the bcl-X gene is a favoured insertion point for the MuLV family of retroviruses. Little is known about what determines the choice of a chromosomal DNA target site during infection. In vivo, in the absence of selection, it seems that all regions of the genome are accessible to retroviral integration, although some sites are used at a higher frequency than expected for random integration (Engelman, 1994) . It is believed that the DNA structure but not the sequence of these integration hot spots could favour retroviral insertion (Engelman, 1994; Muller and Varmus, 1994; Mielke et al., 1996) . An integration preference for actively transcribed DNA or DNAse I hypersensitive sites has also been described (Engelman, 1994) . Although the existence of a preferential insertion site in the 5' region of the bcl-X gene cannot be entirely excluded, this is relatively unlikely. This study is the ®rst report of retroviral insertion in that gene (for review see Jonkers and Berns, 1996) . Furthermore, Bcl-2 and Bcl-X, two functionally close members of the Bcl-2 family inhibit apoptosis induced by c-myc overexpression (Fanidi et al., 1992; Chao et al., 1995; Nass et al., 1996) and bcl-2 has been shown to cooperate with c-myc in tumour formation in transgenic mice (Vaux et al., 1988; Strasser et al., 1990; Jonkers and Berns, 1996) . However, neither of these genes have been identi®ed in retroviral insertion experiments aimed at identifying oncogenes cooperating with c-myc in tumour formation, indicating that a strong bias for insertion into these genes does not exist in those experimental conditions. Hence the preferential insertion in the bcl-X gene we have found, using our selection protocol and criteria, argues that bcl-X is the major pleiotropic anti-apoptotic gene which does not induce proliferation in the absence of growth factor in Baf-3 cells.
We have previously shown that overexpression of two other Bcl-2 family members, Bcl-2 and NR13 lead to a similar apoptosis-resistant phenotype in Baf-3 cells (Marvel et al., 1994; Mangeney et al., 1996) . However, insertion leading to overexpression of these two genes was not found in these experiments. One possible explanation for this apparent discrepancy could be that retroviral insertion does not lead to a level of overexpression of these genes which would allow Baf-3 cells to survive our selection protocol. Indeed levels of Bcl-2 overexpression which are necessary to inhibit the apoptosis of Baf-3 cells are much higher than those observed for Bcl-X (data not shown). Moreover, we have also shown that Bcl-X but not Bcl-2 is involved in the IL-3 dependent inhibition of apoptosis in Baf-3 cells (Leverrier et al., 1997) . This suggests that in other cell types where protection against apoptosis is mediated by other Bcl-2 family members, one would expect to reveal those genes using similar selection criteria.
None of the mutants proliferated signi®cantly in the absence of growth factors. This phenotype is similar to the one obtained when other Bcl-2 family members are overexpressed in Baf-3 cells (Marvel et al., 1994; Mangeney et al., 1996) . This non cycling phenotype results from the absence of mitogenic signals and from the anti-mitotic activity of Bcl-2 family members which has recently been described (Marvel et al., 1994; Borner, 1996; Linette et al., 1996; Vairo et al., 1996) . Identi®cation of other genes capable of pleiotropic inhibition of apoptosis while allowing or triggering proliferation might also help to shed some light on the regulation of cell death. Such mutants have been obtained and are currently under investigation.
Materials and methods
Cell culture and reagents
The bone marrow derived IL-3 dependent Baf-3 cells (Rodriguez-Tarduchy et al., 1990) were maintained in DMEM containing 6% foetal calf serum (FCS, Boehringer Mannheim), 2 mM L-glutamine (Gibco) and 5% WEHI 3B cell-conditioned medium as a source of IL-3. Cells were grown at a density of 5610 4 to 5610 5 per ml. PAPM3 cells were cultivated in DMEM containing 5% new born calf serum (NBCS, Gibco), 2 mM L-glutamine. TEL671 were cultivated in DMEM containing 6% foetal calf serum (Gibco), 2 mM L-glutamine. To remove IL-3, cells were washed twice in DMEM/FCS 6%.
Retroviral infection of Baf-3 cells
Baf-3 cells (6 ± 7.10 7 ) were infected by co-culture with M3Pneo-sup producing cells (PAPM3 cells), or with supernatant of pMFG nlsLacZ producing cells (TEL671 cells) (Stocking et al., 1993; Cosset et al., 1995) . For mutagenesis experiments 1 and 2, Baf-3 cells were cocultured for 48 h with semi-con¯uent PAPM3 cells. Polybren at 8 mg/ml (Sigma) and 5% NBCS were added to the Baf-3 growth medium. For the third mutagenesis, one volume of viral supernatant from TEL671 cells was added to three volumes of Baf-3 cells at a density of 2.10 5 cells/ml. After 4 h of culture, in presence of 8 mg/ ml polybren, cells were washed and cultured for another 2 days to allow provirus integration and the resulting expression or modi®cation of neighbouring cellular genes to occur. Thereafter, IL-3 starvation-induced-apoptosis resistant cells were selected. An aliquot of cells was used to measure the percentage of infected cells expressing the reporter gene. For mutagenesis 1 and 2, the percentage of neomycin resistant cells was calculated from the frequency of G418 resistant cells measured by limiting dilution in the presence or absence of G418. Five percent and 1.25% of cells were resistant to G418 in mutagenesis 1 and 2 respectively. For mutagenesis 3 the percentage of b-galactosidase positive cells was determined by FACscan analysis (Becton-Dickinson) using CMFDG (Molecular Probes) as a substrate. In that experiment 29% of the cells expressed the bgal gene following retroviral infection.
Selection of apoptosis resistant mutants
Two days after infection, cells were grown in the absence of IL-3 until more than 95% of the cells were dead (approximately 30 h). In some cultures FCS was also removed. Dead cells were eliminated by Ficoll density gradient (Lympholyte-M, Cedarlane laboratories, Hornby, Canada) and surviving cells were cloned in absence of IL-3 in Methocel MC 1.5% (methylcellulose, Fluka) solubilized in DMEM containing 6% FCS and 2 mM glutamine. IL-3 was added to dishes after 30 h culture. In mutagenesis 1 and 2 Baf-3 cells with an integrated M3Pneo-sup provirus were selected with G-418 (2 mg/ml, Gibco) during the Methocel MC cloning step. After 10 days culture individual clones were expanded in liquid medium and their resistance to apoptosis induced by IL-3 starvation or drugs was monitored. Clones which were strongly resistant to apoptosis were recloned by limiting dilution before being characterized in details.
Apoptosis measurement
Resistance to apoptosis was monitored after 20 h of IL-3 deprivation in the presence or absence of drugs. Etoposide (Brystol-Myers), staurosporine (Boehringer Mannheim) and cyclosporin A (Sandoz) were used at 1 mg/ml, 0.2 mM and 50 mg/ml respectively.
The percentage of viable cells was measured by Propidium Iodide (PI) exclusion. 5.10 3 to 10 4 cells were incubated in the presence of 5 mg/ml of PI and analysed on a FACscan (Becton-Dickinson) using a FSC/SSC gate to exclude debris. For each time point at least 3000 cells were analysed on FSC/ FL2 dot plot. This staining protocol allows the distinction between dead (FL-2 bright, FSC low), apoptotic (FL2 dull, FSC intermediate) and live cells (FL-2 negative, FSC high) (Leverrier et al., 1997) . The percentage of viable cells corresponds to the percentage of FL-2 negative cells.
BrdU staining
5.10
5 cells were labelled with BrdU (32 mM, Sigma) for 30 min. Cells were washed in PBS, ®xed in 70% ethanol/ 30% PBS and rinsed twice in PBT (PBS, 0.5 mg/ml BSA, 0.1% Tween 20). DNA was denatured in 2N HCl for 30 min at room temperature. After one wash in 0.1 M Na 2 B 4 O 7 and two washes in PBT, cells were incubated for 30 min at room temperature with anti-BrdU-FITC monoclonal antibodies (Becton-Dickinson) diluted 1/10 in PBT. Cells were washed twice in PBT and incubated with 100 mg/ml RNAse and 2 mg/ml PI for 30 min at 378C. BrdU labelling (FL1-H) and PI (FL2-H) were analysed on 10 000 cells excluding sub-G1 apoptotic cells at the acquisition level on a FACscan.
Isolation of genomic DNA and Southern blot analysis
Genomic DNA was isolated from 10 7 cells using QIAamp Blood Kit (Quiagen) and restriction enzyme digestions were carried out as recommended by the supplier (Eurogentech). 10 mg of digested DNA was separated on a 0.8% agarose gel, transferred to Hybond N+ (Amersham) nylon membrane, hybridized overnight at 428C with 32 P-labelled probes and washed using a standard protocol.
RNA preparation and Northern blot analysis
Total cellular RNA was isolated by the RNA Now method (Biogentex). 10 mg of total RNA were separated on 1% agarose formaldehyde gel, transferred to Hybond N (Amersham) nylon membrane, hybridized overnight at 428C with 32 P-labelled probes and washed using a standard protocol.
DNA probes
The murine Bcl-X probe is a 0.8 kbp SacI/XhoI fragment and the murine Bax probe is a 0.6 kbp KpnI/SacI fragment, both containing the complete coding region (kind gift of Prof D Loh). The murine Bcl-2 probe is a 0.6 kbp BamHI/HindIII fragment containing the ®rst coding exon (kind gift of Prof G Nunez). The murine GAPDH probe is a 1 kbp PstI fragment. The Neo probe is a NcoI/PstI 0.38 kbp fragment. The LacZ probe is a 3 kbp EcoRI fragment.
The U3MPSV probe is a 220 bp PCR fragment obtained with the 5'primer 5'-GTAGGTTTGGCAAGC-3' and the 3 primer 5'-CAGGAACTGCTTACC-3' both hybridizing in the U3 region of the MPSV derived LTR. This stretch of MPSV U3 was chosen because of its low homology to the MuLV U3 region. As a consequence it allows us to detect speci®cally MPSV LTR as it does only marginally hybridize with endogenous LTR.
Measurement of Bcl-X protein expression
Cells were washed in cold PBS and pellets were lysed for 10 min at 48C in lysis buer (10 mM KCl, 10 mM Tris HCl pH 8, 1 mM MgCl 2 , 0.1% NP40, 0.02 M E64, 0.1 mM phenantroline, 0.1 mM DCI). Protein content was measured using the protein quanti®cation kit mBCA (Pierce). 80 mg of total protein were separated on 12.5% polyacrylamide SDS ± PAGE gels. Gels were electroblotted onto nitro-cellulose membranes as described in (Leverrier et al., 1997) . Murine Bcl-XL was detected using a monoclonal antibody speci®c for murine Bcl-XL (B22620, Transduction Laboratories). Bound antibodies were revealed with HRP coupled rabbit anti-mouse antibodies and the chemoluminescence detection system from DuPont NEN. As previously reported, Bcl-X is detected as a doublet.
Sequencing
Sequencing reaction was performed on double stranded DNA with the¯uorescent dideoxynucleotide terminators sequencing kit (ABI PRISM Dye Terminator Cycle Sequencing Kit, Applied Biosystem Inc, a division of the Perkin-Elmer Corporation). Reaction products were analysed on a automated DNA sequencer (373A DNA, Applied Biosystem Inc, a division of the Perkin Elmer Corporation).
PCR
Long template PCR (Boehringer Manheim) was performed to localize the insertion site of the retroviruses in the bcl-X gene. Schematic localization of the primers are indicated in Figure 6a .
Primer A: 5'-CAGGAACTGCTTACC-3', primer B: 5'-GTAGGTTTGGCAAGC-3', primer C: 5'-AAAGTCGAC-CACCAGCTCCCGGTT-3', primer D: 5'-GCTGGGCTCA-CTCTTCAGTCGGAA-3'.
